Penn Medicine Provider
Interventional Pulmonology
Anil Vachani, MD
4.8
(30)
Sees patients age 18 and up
Harron Lung Center Perelman
Make an appointmentCall 215-615-5864

About me

  • Director of Clinical Research, Section of Interventional Pulmonary and Thoracic Oncology
  • Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center

Education and training

  • Medical School: University of California San Francisco
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.8

30 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2019
5.0
5.0
Dr. Vachani is excellent - experienced & thorough.
May 2018
5.0
5.0
I was particularly impressed with doctor's caring manner and ability to explain medical information in plain language!
October 2017
5.0
5.0
Doctor was awesome, courteous and professional!
May 2017
5.0
5.0
He's very good with condition about my health.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Vachani is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Caruso CR, Kim RY, Rendle KA, Vachani A. Evaluating the Non-Malignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification , Chest: 2025

Dako F, Karasek P, Seward J, White K, Vachani A, Rendle K, Guerra C. Measuring Health-Related Social Risks in a Lung Cancer Screening Cohort , J Am Coll Radiol: 2025

Carroll NM, Eisenstein J, Wain KF, Freml JM, Greenlee RT, Honda SA, Neslund-Dudas C, Rendle KA, Vachani A, Ritzwoller DP. Patterns of recurrence among adults diagnosed with screen-detected lung cancer , Cancer Epidemiol, 95: 2025

Elston Lafata J, Rendle KA, Wainwright JV, Cooley ME, Vachani A, Neslund-Dudas C, Odelberg MR, Alcaro L, Staresinic C, Alexander GL, Carlson RB, Schapira MM. Characterizing the Design of and Emerging Evidence for Health Care Organization-Based Lung Cancer Screening Interventions: A Systematic Review , MDM Policy Pract, 10(1): 2025,1-35

Kim RY, Rendle KA, Mitra N, Neslund-Dudas C, Greenlee RT, Honda SA, Schapira MM, Simoff MJ, Jeon J, Meza R, Ritzwoller DP, Vachani A. Adherence to Annual Lung Cancer Screening and Rates of Cancer Diagnosis , JAMA Netw Open, 8: 2025,e250942

Carroll NM, Eisenstein J, Freml JM, Burnett-Hartman AN, Greenlee RT, Honda SA, Neslund-Dudas CM, Rendle KA, Vachani A, Ritzwoller DP. Association of systemic therapy with survival among adults with advanced non-small cell lung cancer , Transl Lung Cancer Res, 14(1): 2025,176-193

Rendle K.A., Saia C.A., Vachani A., Burnett-Hartman A.N., Doria-Rose V.P., Beucker S., Neslund-Dudas C., Oshiro C., Kim R.Y., Elston-Lafata J., Honda S.A., Ritzwoller D., Wainwright J.V., Mitra N., Greenlee R.T. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice: A Retrospective Cohort Study , Ann Intern Med, 177(1): 2024 ,18-28

Ost DE, Maldonado F, Shafrin J, Kim J, Marin MA, Amos TB, Hertz DS, Kalsekar I, Vachani A. Economic Value of Bronchoscopy Technologies that Improves Sensitivity for Malignancy for Peripheral Pulmonary Lesions , Ann Am Thorac Soc, 21(12): 2024,1759-1769

Mazzone PJ, Bach PB, Carey J, Schonewolf CA, Bognar K, Ahluwalia MS, Cruz-Correa M, Gierada D, Kotagiri S, Lloyd K, Maldonado F, Ortendahl JD, Sequist LV, Silvestri GA, Tanner N, Thompson JC, Vachani A, Wong KK, Zaidi AH, Catallini J, Gershman A, Lumbard K, Millberg LK, Nawrocki J, Portwood C, Rangnekar A, Sheridan CC, Trivedi N, Wu T, Zong Y, Cotton L, Ryan A, Cisar C, Leal A, Dracopoli NC, Scharpf RB, Velculescu VE, Pike LRG. Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection , Cancer Discov, 14(11): 2024,2224-2242

Wainwright JV, Aggarwal C, Beucker S, Dougherty DW, Gabriel PE, Jacobs LA, Kalman J, Linn KA, Martella AO, Mehta SJ, Rhodes CM, Roy M, Schapira MM, Shulman LN, Steltz J, Stephens Shields AJ, Tan ASL, Thompson JC, Toneff H, Wender RC, Zeb S, Rendle KA, Vachani A, Bekelman JE; Penn TRACE. University of Pennsylvania Telehealth Research Center of Excellence , J Natl Cancer Inst Monogr, 2024: 2024,62-69